PT - JOURNAL ARTICLE AU - Neumann, Johannes T. AU - Riaz, Moeen AU - Bakshi, Andrew AU - Polekhina, Galina AU - Thao, Le T. P. AU - Nelson, Mark R. AU - Woods, Robyn L. AU - Abraham, Gad AU - Inouye, Michael AU - Reid, Christopher M. AU - Tonkin, Andrew M. AU - McNeil, John AU - Lacaze, Paul TI - A polygenic risk score for coronary heart disease performs well in individuals aged 70 years and older AID - 10.1101/2021.03.23.21254144 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.23.21254144 4099 - http://medrxiv.org/content/early/2021/03/26/2021.03.23.21254144.short 4100 - http://medrxiv.org/content/early/2021/03/26/2021.03.23.21254144.full AB - Background The use of a polygenic risk score (PRS) to predict coronary heart disease (CHD) events has been demonstrated in the general adult population. However, whether predictive performance extends to older individuals is unclear.Aim To evaluate the predictive value of a PRS for incident CHD events in a prospective cohort of individuals aged 70 years and older.Methods We used data from 12,792 genotyped participants of the ASPREE trial, a randomized placebo-controlled trial investigating the effect of daily 100mg aspirin on disability-free survival in healthy older people. Participants had no previous history of diagnosed atherothrombotic cardiovascular events, dementia, or persistent physical disability at enrolment. We calculated a PRS comprising 1.7 million genetic variants (metaGRS). The primary outcome was a composite of incident myocardial infarction or CHD death over 5 years.Results At baseline, the median population age was 73.9 years and 54.9% were female. In total, 254 incident CHD events occurred. When the PRS was added to conventional risk factors, it was independently associated with CHD (hazard ratio 1.24 [95% confidence interval [CI] 1.08-1.42], p=0.002). The AUC of the conventional model was 70.53 (95%CI 67.00-74.06), and after inclusion of the PRS increased to 71.78 (95%CI 68.32-75.24, p=0.019), demonstrating improved prediction. Reclassification was also improved, as the continuous net reclassification index after adding PRS to the conventional model was 0.25 (95%CI 0.15-0.28).Conclusions A PRS for CHD performs well in older people, suggesting that the clinical utility of genomic risk prediction for CHD extends to this distinct high-risk subgroup.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01038583Funding StatementSupported by the National Institute on Aging and the National Cancer Institute at the National Institutes of Health (grant number U01AG029824); the National Health and Medical Research Council of Australia (grant numbers 334047, 1127060); Monash University and the Victorian Cancer Agency. Genotyping supported by Bioplatforms Australia, National Framework Initiative (2018-2020). J.N. is recipient of a fellowship by the Deutsche Forschungsgemeinschaft (NE 2165/1-1). C.M.R. is supported through a NHMRC Principal Research Fellowship (APP 1136372). P.L is supported by a National Heart Foundation Future Leader Fellowship (102604).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Alfred Hospital Human Research Ethics CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and code that support the findings of this study are available from the corresponding author upon reasonable request.